Background: Recent studies have cast doubt on the benefit of cardiac resynchronization
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …

Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …

Background The impact of implantable defibrillator therapy on outcomes of patients with
nonischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy …

Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …

Background: Patients with nonischemic dilated cardiomyopathy (DCM) may be at lower risk
for ventricular arrhythmias compared with those with ischemic cardiomyopathy (ICM). In …

Abstract Background The Resynchronization–Defibrillation for Ambulatory Heart Failure
Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients …

Objectives: This study sought to evaluate the efficacy of implantable cardioverter-defibrillator
(ICD) therapy with or without cardiac resynchronization therapy (CRT) in patients with …

BACKGROUND: Cardiac resynchronization therapy (CRT) is a therapy of proven benefit in
patients with advanced heart failure. Identifying potential responders remains challenging …

Cardiac resynchronization therapy (CRT) using a biventricular pacing system has been an
effective therapeutic strategy in patients with symptomatic heart failure with a reduced left …

Background—Cardiac resynchronization therapy (CRT) alone or combined with an
implantable defibrillator (CRT-D) has been shown to improve exercise capacity and quality …